Physician profile
Vivek Bahl
NPI 1154389138
$12,989.91
in general payments reported to CMS, 2019-2025
50 companies · $2,260 in 2025
The $2,260 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,135 · 2020: $459 · 2021: $1,182 · 2022: $2,177 · 2023: $1,948 · 2024: $1,829 · 2025: $2,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,938 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,937.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $978.38 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Pamira |
| Pfizer INC. | $848.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $826.51 | 2019-2025 | Farxiga, Wainua |
| Amgen INC. | $772.33 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $716.41 | 2019-2025 | |
| Medtronic, INC. | $674.69 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Abiomed | $573.79 | 2019-2025 | Impella |
| Boston Scientific Corporation | $568.61 | 2021-2025 | General - Vascular Intervention, Enroute Transcarotid Neuroprotection System, Avvigo Guidance System |
| E.R. Squibb & Sons, L.L.C. | $510.59 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $466.98 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $415.52 | 2019-2025 | Lifevest |
| Abbott Laboratories | $379.84 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Cook Medical LLC | $363.29 | 2019-2023 | Advance, Zilver Ptx, Tornado |
| Abbvie INC. | $360.34 | 2022-2024 | Ubrelvy, Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.15 | 2019-2025 | Jardiance |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $308.13 | 2019-2025 | Tr Band |
| Edwards Lifesciences Corporation | $299.91 | 2024-2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $293.41 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $285.94 | 2021-2025 | Verquvo |
| Penumbra, INC. | $284.95 | 2019-2023 | Indigo System |
| Shockwave Medical, INC | $233.88 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $198.94 | 2022 | |
| Cardiovascular Systems INC. | $186.21 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $172.64 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $166.94 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $164.16 | 2023-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $143.62 | 2021-2024 | |
| Arbor Pharmaceuticals, INC. | $141.81 | 2019-2021 | |
| Cardiva Medical, INC. | $141.66 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Optowire |
| Gilead Sciences, INC. | $123.73 | 2019 | |
| W. L. Gore & Associates, INC. | $123.19 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Covidien LP | $102.40 | 2019 | |
| Heartflow, INC. | $99.04 | 2024-2025 | |
| Cordis US Corp. | $98.47 | 2022-2023 | Brite Tip Radianz |
| Regeneron Healthcare Solutions, INC. | $83.17 | 2019 | |
| Atricure, INC. | $76.91 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Baxter Healthcare | $76.74 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Silk Road Medical, INC. | $73.82 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Sanofi-Aventis U.S. LLC | $62.79 | 2019 | |
| Esperion Therapeutics, INC. | $42.81 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $41.06 | 2023 | |
| Amarin Pharma, INC. | $34.91 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $25.43 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $25.07 | 2025 | Attruby |
| Lilly USA, LLC | $24.78 | 2025 | Zepbound, Mounjaro |
| Kowa Pharmaceuticals America, INC. | $19.66 | 2021 | |
| Chiesi USA, INC. | $18.29 | 2024 | Kengreal |
| G Medical Diagnostic Services, INC. | $17.50 | 2022 | |
| Daiichi Sankyo INC. | $14.84 | 2025 | Injectafer |
| Tactile Systems Technology INC | $14.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Bahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.